Ticker Details
Sutro Biopharma, Inc.
IPO Date:	October 12, 2018
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$348.87M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.36 | 3.86%
Avg Daily Range (30 D):	$0.88 | 3.61%
Avg Daily Range (90 D):	$1.19 | 4.05%

Institutional Daily Volume
Avg Daily Volume:	.43M
Avg Daily Volume (30 D):	.25M
Avg Daily Volume (90 D):	.27M

Trade Size
Avg Trade Size (Sh.):	119
Avg Trade Size (Sh.) (30 D):	54
Avg Trade Size (Sh.) (90 D):	53

Institutional Trades
Total Institutional Trades:	755
Avg Institutional Trade:	$1.61M
Avg Institutional Trade (30 D):	$.87M
Avg Institutional Trade (90 D):	$1.58M
Avg Institutional Trade Volume:	.02M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.7M
Avg Closing Trade (30 D):	$.73M
Avg Closing Trade (90 D):	$2.23M
Avg Closing Volume:	23.29K

News

Apr 19, 2026 @ 11:45 PM Sutro Biopharma Presents Promising Preclinical Dat... Source: Na

Feb 10, 2026 @ 12:00 PM Sutro Biopharma Announces Pricing of $110.0 millio... Source: Na

Dec 3, 2025 @ 1:00 PM Sutro Biopharma Announces First Cohort of Patients... Source: Sutro Biopharma

Nov 12, 2025 @ 3:00 PM Sutro Biopharma Highlights Next-Generation ADC Inn... Source: Sutro Biopharma

Nov 3, 2025 @ 1:00 PM Sutro Biopharma Announces Participation at the 16t... Source: Sutro Biopharma

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-26.64	$-2.33	$-2.94
Diluted EPS	$-26.64	$-2.33	$-2.94
Revenue	$45.7M	$9.84M	$14.52M
Gross Profit
Net Income / Loss	$-180.64M	$-38.53M	$-38.48M
Operating Income / Loss	$-146.05M	$-29.89M	$-29.66M
Cost of Revenue
Net Cash Flow	$-9.69M	$-19.35M	$15.55M
PE Ratio

Splits
Dec 03, 2025	1:10